Literature DB >> 6256150

des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme.

C Garcia Del Rio, W S Smellie, J J Morton.   

Abstract

The observation that angiotensin III is present in the circulation of the rat in amounts similar to those of angiotensin II has led to the notion that it may, in part, be formed by the action of converting enzyme on des-Asp-angiotensin I without the prior formation of angiotensin II. This possibility was studied in conscious rats using a combination of RIA and chromatographic techniques which allowed the separate measurement of angiotensin I, des-Asp-angiotensin I, angiotensin II, and angiotensin III in rat blood. Infusion of des-Asp1-[Ile5]angiotensin I at 50, 150, and 450 ng/kg . min resulted in a progressive increase in the plasma concentration of angiotensin III up to 279 +/- 50 (SD) pg/ml compared to 9 +/- 9 (SD) pg/ml after dextrose infusion. Regardless of the infusion of des Asp-[Ile5]angiotensin I, plasma angiotensin III made up a constant 46 +/- 8% (+/- SD) of the total immunoactive material, the remainder being composed of smaller metabolic fragments, indicating a rapid rate of clearance of angiotensin III. Captopril completely inhibited the rise in angiotensin III after des-Asp1-[Ile5]angiotensin I infusion. A substance which chromatographed as des-Asp-[Ile5]angiotensin I was detected in rat blood and made up 19% of the angiotensin I immunoactive material, while angiotensin III made up 44% of the angiotensin II immunoactive material. These results confirm that des-Asp1-[Ile5]angiotensin I is a substrate for converting enzyme in the rat, and the presence of a chromatographically similar substance in the circulation suggests that at least part of the angiotensin III in rat blood may be formed by the action of converting enzyme on endogenous des-Asp-angiotensin I. (Endocrinology 108: 406, 1981)

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6256150     DOI: 10.1210/endo-108-2-406

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

Authors:  G P Hodsman; J R Zabludowski; C Zoccali; R Fraser; J J Morton; G D Murray; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

2.  Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat.

Authors:  Rosemary Wangensteen; Manuel Gómez-Guzmán; Inmaculada Banegas; Isabel Rodríguez-Gómez; Rosario Jiménez; Juan Duarte; Joaquín García-Estañ; Félix Vargas
Journal:  Biomedicines       Date:  2022-05-25

3.  Proteolytic processing of angiotensin-I in human blood plasma.

Authors:  Diana Hildebrand; Philipp Merkel; Lars Florian Eggers; Hartmut Schlüter
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

Review 4.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.